Plain-English translation of NCT05577390 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a treatment called INF® Therapy—a hands-on approach designed specifically for nerve pain—works better than standard physical therapy for people with diabetic neuropathy. Neuropathy causes numbness, tingling, burning, and pain, usually in the feet and legs. The study will measure how each treatment affects blood flow, heart function, and nerve symptoms.
Diabetic neuropathy causes real suffering and current treatments don't work well for everyone. Researchers want to know if this specialized nerve therapy offers patients better relief than the physical therapy approaches that are commonly used today.
You likely qualify if…
You likely don't qualify if…
You will attend 11 sessions over several weeks. At the first and last visits, you'll complete questionnaires and have imaging tests to measure nerve and blood vessel health. At your second visit, you'll have an electrocardiogram, blood work, and specialized scans before and after your first treatment. For sessions 2 through 10, you'll receive either INF® Therapy or standard physical therapy—whichever group you're randomly assigned to—with each session lasting 60 minutes. Throughout the study, you'll use a smartphone app to measure your heart rate variability at home on specific days.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States